Logo

Vox Markets

Q&A with Avacta's CEO Alastair Smith

Q&A with Avacta's CEO Alastair Smith

2589 views
2 years ago
Author: Vox Markets

It’s currently a very busy & successful time for Avacta – a leading life sciences firm developing innovative, new cancer treatments & powerful diagnostics.
Hence, I was delighted today to catchup with CEO Alastair Smith, who took me through:

Progress of AVA6000 clinical trial wrt safety, dosing …

Read more
Vox Markets
Company News
trading
investing
stocks
shares
Small caps
Stocks to Follow
Hot Stocks
Stock Market
AVCT
preCISION
AVA6000
Powered bySeeen logo